Zobrazeno 1 - 4
of 4
pro vyhledávání: '"T. A. Stasishkis"'
Autor:
E. V. Esaulenko, K. A. Zakharov, I. S. Alikian, A. A. Sukhoruk, T. A. Stasishkis, A. U. Kovelenov
Publikováno v:
Журнал инфектологии, Vol 10, Iss 3, Pp 108-114 (2018)
Study aims: The study purpose was to analyze the results of the clinical and laboratory monitoring of HBeAg-negative chronic hepatitis B patients after discontinuation of longterm nucleosides analogues antiviral therapy in order to determine further
Externí odkaz:
https://doaj.org/article/b7e612464da54326a126539f090064a2
Publikováno v:
Журнал инфектологии, Vol 1, Iss 4, Pp 72-75 (2014)
Entecavir is a potent and selective guanosine analogue that has demonstrated a significant antiviral efficacy against hepatitis B virus. The purpose of this article was to characterize the response to entecavir and it portability. METHODS: We adminis
Externí odkaz:
https://doaj.org/article/2a1ea3f027c442bab974d333dc81ae8d
Autor:
IV Kritskaya, KE Novak, YuV Ostankova, AYu Kovelenov, VV Tsvetkov, LV Buts, T. A. Stasishkis, EV Khorkova, OM Mikailova, OYu Rishnyak, DS Tyagunov, LV Lyalina, D. E. Valutite
Publikováno v:
ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT. :76-84
Introduction. To achieve the goal of eliminating viral hepatitis by 2030, it is necessary to assess the real situation, improve epidemiological surveillance and prevention of these infections. Objectives: To evaluate the results of epidemiological su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fcf295c0c7249ab5b67717ca96da0cc3
https://doi.org/10.35627/2219-5238/2021-29-8-76-84
https://doi.org/10.35627/2219-5238/2021-29-8-76-84
Autor:
B. B. Rassokhin, E. V. Boeva, S. L. Plavinskiy, L. V. Gutova, Nikolay Belyakov, T. A. Stasishkis, N. B. Khalezova, A. Yu. Kovelenov
Publikováno v:
HIV Infection and Immunosuppressive Disorders. 10:57-66
The materials on psychological and psychosocial status of women with HIV and HCV co-infection [1] with the following assessment of their readiness and ability to undergo treatment of chronic hepatitis C virus and maintenance of treatment compliance t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::781853f80111c0d9b7e0b18375c020e2
https://doi.org/10.22328/2077-9828-2018-10-4-57-66
https://doi.org/10.22328/2077-9828-2018-10-4-57-66